Exagen Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.87

+0.28 (+4.25%)

As of Aug 15, 2:15 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +641.2% upside

Low Target $37.48

Average Target $50.92

High Target $70.07

Current Price $6.87

Current
$6.87

Target
$50.92

$37.48 $50.92 avg $70.07

Scenario Analysis

Bear Case

$37.48

445.6%

Low target

Base Case

$50.92

+641.2%

Avg target

Bull Case

$70.07

+919.9%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$12.23

-43.8% from high

52-Week Low

$2.59

+165.3% from low

Target vs 52W High

$50.92

+316.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%